Available Azelaic Acid Products
Topical azelaic acid is available in two FDA-approved formulations: 20% cream and 15% gel, both applied twice daily for acne vulgaris and mild-to-moderate inflammatory acne. 1, 2
FDA-Approved Formulations
Azelaic Acid 20% Cream
- Brand name: AZELEX®
- Indication: Mild to moderate inflammatory acne vulgaris 1
- Dosing: Apply a thin film to affected areas twice daily (morning and evening), gently massaged into skin 1
- Active ingredient: 0.2 gm per gram (20% w/w) 2
- Vehicle components: Cetearyl octanoate, glycerin, glyceryl stearate, propylene glycol, with benzoic acid as preservative 2
Azelaic Acid 15% Gel
- Indication: Papulopustular rosacea 3
- Dosing: Applied twice daily to affected areas 3
- Clinical profile: Established efficacy in multiple studies as monotherapy and in combination with oral doxycycline 3
- Tolerability advantage: Does not induce epidermal permeability barrier impairment 3
Azelaic Acid 15% Foam
- Status: FDA-approved for rosacea 4, 5
- Key advantage: Superior tolerability profile with very low incidence of stinging, burning, and itching compared to gel formulation 3, 5
- Efficacy in acne: Demonstrated effectiveness in moderate-to-severe facial acne vulgaris, with 84% of subjects achieving at least 1-grade improvement and 63% achieving "Clear or Almost Clear" status at 16 weeks 4
- Vehicle benefit: Foam technology provides enhanced convenience and reduced neurosensory cutaneous reactions 5
Clinical Considerations
Mechanism of action: Azelaic acid functions as a comedolytic, antibacterial, and anti-inflammatory agent through antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis, normalization of keratinization, and inhibition of tyrosinase 1, 2, 6
Special populations:
- Pregnancy category B - making it a preferred option during pregnancy 1
- Pediatric use: Safety and effectiveness not established in patients <12 years 1
- Skin of color: Particularly useful in Fitzpatrick skin types IV or greater due to lightening effect on post-inflammatory dyspigmentation 1
Common adverse effects: Pruritus, burning, stinging, tingling, erythema, dryness, rash, peeling, irritation, dermatitis - typically mild and transient 1, 3
Pharmacokinetics: Approximately 4% systemically absorbed after topical application, with negligible cutaneous metabolism and no significant difference from baseline plasma concentrations 2
Formulation Selection Strategy
Choose 20% cream when:
- Treating acne vulgaris as primary indication
- Patient has no history of significant irritation with creams
- Cost is a consideration (older formulation, potentially lower cost)
Choose 15% gel when:
- Treating papulopustular rosacea
- Patient prefers non-greasy formulation
- Combination therapy with oral doxycycline planned 3
Choose 15% foam when:
- Patient has sensitive skin or history of irritation with other vehicles 4, 5
- Treating either acne or rosacea with emphasis on tolerability
- Patient adherence concerns due to cosmetic elegance preferences
Common pitfall: The 15% foam formulation, while better tolerated, may not be covered by all insurance plans as it is a newer formulation. The 20% cream remains the standard for acne vulgaris treatment per guidelines 1.